Health Bulletin 29/November/2022 - Video
Overview
Here are the top health stories for the day:
WHO: Monkeypox new name "Mpox"
Following a series of consultations with global experts, WHO will begin using a new preferred term "mpox" as a synonym for monkeypox. Both names will be used simultaneously for one year while "monkeypox" is phased out.
When the outbreak of monkeypox expanded earlier this year, racist and stigmatizing language online, in other settings, and in some communities was observed and reported to WHO. In several meetings, public and private, a number of individuals and countries raised concerns and asked WHO to propose a way forward to change the name.
Assigning names to new and, very exceptionally, to existing diseases is the responsibility of WHO under the International Classification of Diseases (ICD) and the WHO Family of International Health Related Classifications through a consultative process that includes WHO Member States.
Check out the Medical Dialogues official site for more health news:
NEET not required: Nursing admissions only on basis of Physics, Chemistry and Biology marks in Maharashtra
As a one time measure, the Aurangabad Bench of Bombay High Court has ordered that admission to nursing courses will be done on the basis of the Physics, Chemistry and Biology marks of Class XII examination instead of the National Eligibility cum Entrance Test (NEET).
However, the Court has clarified that this decision shall not affect the first round of admissions that filled in around 1,200 seats. Directing the Indian Nursing Council to coordinate with the Commissioner of CET Cell, the HC bench comprising of Justices Sanjay A. Deshmukh and Ravindra V. Ghuge has also clarified that the entire admission process should not continue beyond December 31, 2022.
For more details, check out the link given below:
Mankind Pharma buys majority stake in Upakarma Ayurveda
Mankind Pharma has recently acquired a majority stake in Upakarma Ayurveda, engaged in developing, manufacturing, and selling ayurvedic and herbal products for an undisclosed amount. The company's decision to invest will empower Upakarma Ayurveda to develop a wider range of products and offerings, the drug firm said in a statement.
"The current lifestyle has become strenuous where people find it difficult to focus on their health. To fulfill their requirements, consumers are considering Ayurvedic remedies for long-term sustenance and boosting immunity over time.
For more details, check out the link given below:
Speakers
